SI
TMDX icon

Sava Infond’s Transmedics TMDX Stock Holding History

Sava Infond’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,100
Closed -$308K – 248
2026
Q1 		$308K Hold
3,100
– – 0.04% 168
2025
Q4 		$377K Buy
3,100
+1,200
+63% +$151K 0.05% 142
2025
Q3 		$213K Sell
1,900
-100
-5% -$11.7K 0.03% 170
2025
Q2 		$268K Sell
2,000
-200
-9% -$22K 0.04% 152
2025
Q1 		$148K Buy
2,200
+700
+47% +$48.1K 0.03% 182
2024
Q4 		$93.5K Buy
+1,500
New +$140K 0.02% 195

Other funds holding TMDX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
STAS
Strong Tower Advisory Services Minneapolis, Minnesota $558M AUM 13.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
KGP
Keystone Global Partners Denver, Colorado $265M AUM 22.65% 1-Year Est. Return
CWMS
CFG Wealth Management Services Indianapolis, Indiana $107M AUM

Sava Infond's TMDX Position: Q2 2026 in Review

Sava Infond sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,100 shares — an estimated $308K sold.

Sava Infond first reported a position in TMDX in Q4 2024 and held it in 6 quarters. The position peaked at $377K in Q4 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Sava Infond reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Sava Infond sold 3,100 Transmedics shares in Q2 2026, an estimated $308K.
  • Sava Infond first reported a position in Transmedics in Q4 2024 and held it in 6 quarters.
  • Sava Infond's Transmedics position peaked at $377K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.